Frost & Sullivan

MARCH 22, 2024

However, the pharma/biopharma industry shows overall stagnant R&D activity. Small-to-mid and emerging biopharma players contribute over 16%. Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth.

Ecosystems 52

Ecosystems Biopharma Biotech Contract research organization 52

Frost & Sullivan

APRIL 25, 2023

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. years, to become a truly global company with a diverse mix of public sector and biopharma clients.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

Jake Jorgovan

FEBRUARY 1, 2024

CSSi LifeSciences CSSi LifeSciences is a global, innovative Contract Research Organization (CRO) and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval. Collaborative Approach: Choose a firm that values collaboration and open communication.

Life science 130

Life science Biotech Biotechnology Engineering 130